scholarly journals AMYOTROPIC LATERAL SCLEROSIS: A REVIEW FROM AN AYURVEDIC PERSPECTIVE

2016 ◽  
Vol 7 (5) ◽  
pp. 17-21
Author(s):  
Gopikrishna S
The Lancet ◽  
1985 ◽  
Vol 326 (8468) ◽  
pp. 1353 ◽  
Author(s):  
RalphM Garruto ◽  
Carol Swyt ◽  
CharlesE Fiori ◽  
Richard Yanagihara ◽  
D.Carleton Gajdusek

2020 ◽  
Vol 21 (18) ◽  
pp. 6938
Author(s):  
Banaja P. Dash ◽  
Marcel Naumann ◽  
Jared Sterneckert ◽  
Andreas Hermann

Amyotropic lateral sclerosis (ALS) is a lethally progressive and irreversible neurodegenerative disease marked by apparent death of motor neurons present in the spinal cord, brain stem and motor cortex. While more and more gene mutants being established for genetic ALS, the vast majority suffer from sporadic ALS (>90%). It has been challenging, thus, to model sporadic ALS which is one reason why the underlying pathophysiology remains elusive and has stalled the development of therapeutic strategies of this progressive motor neuron disease. To further unravel these pathological signaling pathways, human induced pluripotent stem cell (hiPSCs)-derived motor neurons (MNs) from FUS- and SOD1 ALS patients and healthy controls were systematically compared to independent published datasets. Here through this study we created a gene profile of ALS by analyzing the DEGs, the Kyoto encyclopedia of Genes and Genomes (KEGG) pathways, the interactome and the transcription factor profiles (TF) that would identify altered molecular/functional signatures and their interactions at both transcriptional (mRNAs) and translational levels (hub proteins and TFs). Our findings suggest that FUS and SOD1 may develop from dysregulation in several unique pathways and herpes simplex virus (HSV) infection was among the topmost predominant cellular pathways connected to FUS and not to SOD1. In contrast, SOD1 is mainly characterized by alterations in the metabolic pathways and alterations in the neuroactive-ligand–receptor interactions. This suggests that different genetic ALS forms are singular diseases rather than part of a common spectrum. This is important for patient stratification clearly pointing towards the need for individualized medicine approaches in ALS.


2017 ◽  
Vol 2017 ◽  
pp. 1-27 ◽  
Author(s):  
Taiwo Olayemi Elufioye ◽  
Tomayo Ireti Berida ◽  
Solomon Habtemariam

Neuroprotection is the preservation of the structure and function of neurons from insults arising from cellular injuries induced by a variety of agents or neurodegenerative diseases (NDs). The various NDs including Alzheimer’s, Parkinson’s, and Huntington’s diseases as well as amyotropic lateral sclerosis affect millions of people around the world with the main risk factor being advancing age. Each of these diseases affects specific neurons and/or regions in the brain and involves characteristic pathological and molecular features. Hence, several in vitro and in vivo study models specific to each disease have been employed to study NDs with the aim of understanding their underlying mechanisms and identifying new therapeutic strategies. Of the most prevalent drug development efforts employed in the past few decades, mechanisms implicated in the accumulation of protein-based deposits, oxidative stress, neuroinflammation, and certain neurotransmitter deficits such as acetylcholine and dopamine have been scrutinized in great detail. In this review, we presented classical examples of plant-derived neuroprotective agents by highlighting their structural class and specific mechanisms of action. Many of these natural products that have shown therapeutic efficacies appear to be working through the above-mentioned key multiple mechanisms of action.


1998 ◽  
Vol 95 (1) ◽  
pp. 63-70 ◽  
Author(s):  
Y. Liu ◽  
Benjamin R. Brooks ◽  
Naoyuki Taniguchi ◽  
H. A. Hartmann

2013 ◽  
Vol 23 (9) ◽  
pp. 586
Author(s):  
D.M. Freedman ◽  
J. Wu ◽  
S.E. Daugherty ◽  
J.L. Warren ◽  
R.M. Pfeiffer

Sign in / Sign up

Export Citation Format

Share Document